We genotyped two independent samples of 694 and 598 MS patients as well as 845 geographically- and age-matched controls for LMP2 R60H, HLA-A*02 and HLA-DRB1*15 alleles, considering their gender. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.